Shoaib Ahmad Malik

Dr. Shoaib Ahmad Malik

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2010 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
EME Morselli
E Morselli
MMM C Maiuri
M C Maiuri
MMM Markaki
M Markaki
EME Megalou
E Megalou
APA Pasparaki
A Pasparaki
Guido KroemerGuido Kroemer
Guido Kroemer
Caloric restriction and autophagy-inducing pharmacological agents can prolong lifespan in model organisms including mice, flies, and nematodes. In this study, we show that transgenic expression of Sirtuin-1 induces autophagy in human cells in vitro and in Caenorhabditis elegans in vivo. The knockdown or knockout of Sirtuin-1 prevented the induction of autophagy by resveratrol and by nutrient deprivation in human cells as well as by dietary restriction in C. elegans. Conversely, Sirtuin-1 was not required for the induction of autophagy by rapamycin or p53 inhibition, neither in human cells nor in C. elegans. The knockdown or pharmacological inhibition of Sirtuin-1 enhanced the vulnerability of human cells to metabolic stress, unless they were stimulated to undergo autophagy by treatment with rapamycin or p53 inhibition. Along similar lines, resveratrol and dietary restriction only prolonged the lifespan of autophagy-proficient nematodes, whereas these beneficial effects on longevity were abolished by the knockdown of the essential autophagic modulator Beclin-1. We conclude that autophagy is universally required for the lifespan-prolonging effects of caloric restriction and pharmacological Sirtuin-1 activators.

1 March 2014 in Molecular Cell
Verified
Journal Article
Closed access
Guillermo MariñoGuillermo Mariño
Guillermo Mariño
FPFederico Pietrocola
Federico Pietrocola
Tobias EisenbergTobias Eisenberg
Tobias Eisenberg
YKYongli Kong
Yongli Kong
SMShoaib Ahmad Malik
Shoaib Ahmad Malik
Guido KroemerGuido Kroemer
Guido Kroemer

1 April 2010 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
MMMaria Chiara Maiuri
Maria Chiara Maiuri
LGLorenzo Galluzzi
Lorenzo Galluzzi
EMEugenia Morselli
Eugenia Morselli
OKOliver Kepp
Oliver Kepp
SMShoaib Ahmad Malik
Shoaib Ahmad Malik
Guido KroemerGuido Kroemer
Guido Kroemer

21 February 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
EMEugenia Morselli
Eugenia Morselli
Guillermo MariñoGuillermo Mariño
Guillermo Mariño
MBMartin V. Bennetzen
Martin V. Bennetzen
Tobias EisenbergTobias Eisenberg
Tobias Eisenberg
EMEvgenia Megalou
Evgenia Megalou
Guido KroemerGuido Kroemer
Guido Kroemer
Autophagy protects organelles, cells, and organisms against several stress conditions. Induction of autophagy by resveratrol requires the nicotinamide adenine dinucleotide–dependent deacetylase sirtuin 1 (SIRT1). In this paper, we show that the acetylase inhibitor spermidine stimulates autophagy independent of SIRT1 in human and yeast cells as well as in nematodes. Although resveratrol and spermidine ignite autophagy through distinct mechanisms, these compounds stimulate convergent pathways that culminate in concordant modifications of the acetylproteome. Both agents favor convergent deacetylation and acetylation reactions in the cytosol and in the nucleus, respectively. Both resveratrol and spermidine were able to induce autophagy in cytoplasts (enucleated cells). Moreover, a cytoplasm-restricted mutant of SIRT1 could stimulate autophagy, suggesting that cytoplasmic deacetylation reactions dictate the autophagic cascade. At doses at which neither resveratrol nor spermidine stimulated autophagy alone, these agents synergistically induced autophagy. Altogether, these data underscore the importance of an autophagy regulatory network of antagonistic deacetylases and acetylases that can be pharmacologically manipulated.

1 December 2012 in Molecular Cell
Verified
Journal Article
Closed access
SSShensi Shen
Shensi Shen
MNMireia Niso-Santano
Mireia Niso-Santano
SASandy Adjemian
Sandy Adjemian
TTTetsuo Takehara
Tetsuo Takehara
SMShoaib Ahmad Malik
Shoaib Ahmad Malik
Guido KroemerGuido Kroemer
Guido Kroemer

15 May 2009 in Cell Cycle
Verified
Journal Article
Open access
MMMaria Chiara Maiuri
Maria Chiara Maiuri
SMShoaib Ahmad Malik
Shoaib Ahmad Malik
EMEugenia Morselli
Eugenia Morselli
OKOliver Kepp
Oliver Kepp
ACAlfredo Criollo
Alfredo Criollo
Guido KroemerGuido Kroemer
Guido Kroemer
The oncosuppressor protein p53 regulates autophagy in a dual fashion. The pool of cytoplasmic p53 protein represses autophagy in a transcription-independent fashion, while the pool of nuclear p53 stimulates autophagy through the transactivation of specific genes. Here we report the discovery that Sestrin2, a novel p53 target gene, is involved in the induction of autophagy. Depletion of Sestrin2 by RNA interference reduced the level of autophagy in a panel of p53-sufficient human cancer cell lines responding to distinct autophagy inducers. In quantitative terms, Sestrin2 depletion was as efficient in preventing autophagy induction as was the depletion of Dram, another p53 target gene. Knockout of either Sestrin2 or Dram reduced autophagy elicited by nutrient depletion, rapamycin, lithium or thapsigargin. Moreover, autophagy induction by nutrient depletion or pharmacological stimuli led to an increase in Sestrin2 expression levels in p53-proficient cells. In strict contrast, the depletion of Sestrin2 or Dr...